Driehaus Capital Management LLC Novo Cure LTD Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$68.3 - $93.8 $535,472 - $735,392	-7,840 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $356,313 - $563,328	-5,760 Reduced 42.35%	7,840 $586,000
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $574,192 - $859,928	13,600 New	13,600 $860,000
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $4.48 Million - $8.2 Million	-155,817 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $3.6 Million - $5.9 Million	112,545 Added 260.09%	155,817 $8.17 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $858,949 - $1.38 Million	43,272 New	43,272 $1.35 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.